Medicine and Dentistry
Pancreas Cancer
100%
Surgery
92%
Cholangiocarcinoma
71%
Gemcitabine
57%
Neoplasm
51%
Recurrent Disease
42%
Pancreas Adenocarcinoma
35%
Pancreaticoduodenectomy
33%
Neoadjuvant Chemotherapy
30%
Chemoradiation Therapy
24%
Head Cancer
23%
Liver Metastasis
23%
Bile Duct
21%
Distal Pancreatectomy
21%
Metastatic Carcinoma
20%
Hepatic Portal Vein
20%
Overall Survival
17%
Common Hepatic Artery
17%
Neoadjuvant Therapy
16%
Cytotechnology
16%
Laparoscopic Surgery
14%
Pancreatectomy
13%
Malignant Neoplasm
13%
Paclitaxel
12%
Diseases
12%
Multivariate Analysis
12%
Ascites Fluid Cytology
12%
Chemoradiotherapy
11%
Adjuvant Chemotherapy
11%
Chronic Pancreatitis
11%
CA19-9
11%
Computer Assisted Tomography
11%
Celiac Artery
11%
Lymph Node Metastasis
11%
Neuroendocrine Tumor
11%
Intraductal Papillary Mucinous Tumor
11%
Tumor Marker
11%
Hepatectomy
10%
Adverse Event
10%
Recurrence Free Survival
10%
Nutritional Status
10%
Adjuvant Therapy
10%
Postoperative Complication
9%
Cancer
9%
Tail
9%
Proteomics
9%
Survival Rate
8%
Multidetector Computed Tomography
8%
Radiation Therapy
8%
Pancreaticojejunostomy
8%
Pharmacology, Toxicology and Pharmaceutical Science
Pancreas Cancer
32%
Bile Duct Carcinoma
18%
Chemoradiation Therapy
18%
Recurrent Disease
16%
Gemcitabine
15%
Chemotherapy
15%
Neoplasm
11%
Malignant Neoplasm
10%
Adverse Event
9%
Pancreas Fistula
7%
Liver Metastasis
7%
Colorectal Carcinoma
7%
Receptor
6%
Disease Free Survival
5%
Clinical Trial
5%
Tumor Marker
5%
Pancreas Adenocarcinoma
5%
Carcinoembryonic Antigen
5%